Your search for ‘Smart & Biggar’ returned 2,497 results

Paragraph 9(1)(k) of Canada’s Trademarks Act prohibits a person from adopting a trademark consisting of, or so nearly resembling as to be likely to be mistaken for, "any matter that may falsely suggest a connection with any living individual".

With the Paris climate agreement having recently come into effect, climate change mitigation technologies have been the focus of widespread discussion and debate.

As reported here, on May 16, 2017, Minister of Health Jane Philpott announced a consultation regarding proposed amendments to the Patented Medicines Regulations that would significantly affect the PMPRB's approach to drug price evaluation.

As recently reported, Bill C-8, the Combating Counterfeit Products Act, received Royal Assent and became law on December 9, 2014.

A recent case in the Court of Quebec ( Quebec (Attorney General) c. 156158 Canada Inc. (Boulangerie Maxie's)) provides clarification regarding what is meant by the term "markedly predominant" and confirms that a non-registered common law trademark can qualify as an exemption from the Charter of the French Language.

Quebec's new generic top level domain (gTLD) —.quebec — is scheduled for general availability November 18, 2014. The .quebec domain will be of interest to any brand owners conducting business in La belle province.

On March 24, 2022, the Supreme Court of Canada denied Teksavvy Solutions Inc's application for leave to appeal a decision of the Federal Court of Appeal (2021 FCA 100)...

In a step towards ratifying the Canada-United States-Mexico Agreement (CUSMA), the Canadian government introduced Bill C-100, entitled "An Act to implement the Agreement between Canada ...

Health Canada has secured a permanent injunction against Canlab Research, a Quebec-based online retailer, preventing the company from manufacturing, distributing, or selling unauthorized injectable peptides in Canada. This enforcement action follows years of regulatory warnings and provisional court orders aimed at stopping the illegal sale of peptide drugs promoted with unproven health claims for anti-aging, weight loss, and athletic performance.

As we previously reported, agile licensing amendments to the Food and Drug Regulations and Medical Devices Regulations were registered on November 29, 2024.

Le 18 septembre 2025, L'Agence des médicaments du Canada a lancé sa nouvelle stratégie visant l'amélioration de la prescription et de l'utilisation appropriées...

Le 1er janvier 2026, les Lignes directrices pour le personnel du CEPMB entreront en vigueur. En novembre dernier, le Conseil d'examen du prix des médicaments brevetés...

Further to our June 1, 2020 update, regulations amending the coming into force date of the Regulations Amending the Patented Medicines Regulations

There has been considerable controversy in the United States in recent years about which types of inventions are eligible subject matter for patenting.

Clearing rights to use a photograph can be nuanced. A recent decision out of Quebec highlights the importance of clearing rights both of photographers as well as of people appearing in photos.

On June 30, 2025, the Patented Medicine Prices Review Board (PMPRB) published its new Guidelines for PMPRB Staff, which will come into force on January 1, 2026.

On November 20, 2024, the Federal Court dismissed EMD Serono (Serono)'s judicial review of the Minister of Health's decision to list Canadian Patent No. 3,087,419 (419 Patent)...

BREXIT is near and the clones are coming! As of January 1, 2021, trademarks registered at the European Union Intellectual Property Office